Jun 10, 2020
COTA Supports FDA Assessment of Real-World Data through Membership in COVID-19 Evidence Accelerator
Mar 05, 2020
COTA Appoints C.K. Wang, M.D. as New Chief Medical Officer
Aug 06, 2019
Initial Results of Real-World Evidence Pilot Study Published in JCO Clinical Cancer Informatics
Aug 01, 2019
COTA, Inc. Announces Headquarter Relocation to Boston for Continued Growth
Jul 25, 2019
COTA Welcomes Daniel Lane as Vice President for HEOR to Drive Outcomes-Based Research in Oncology
Feb 04, 2019
COTA, Inc. to Showcase the Importance of Real-World Evidence at HIMSS19
Oct 30, 2018
Cota Brings on Innovative Veteran CEO to Drive Next Phase of Growth and Delivery of Breakthrough Technology and Insights
Apr 27, 2018
Cota Founder and Executive Chairman to Present at the Vatican's Unite to Cure Conference
Apr 19, 2018
Cota Chief Medical Officer to Present at HLTH
Mar 15, 2018
Cota Chief Scientific Officer to Present at the ACCC Annual Meeting & Cancer Center Business Summit
Mar 07, 2018
Cota Executives to Present at HIMSS18 on Using a Precise Disease Classification Tool to Optimize Bundled Payment Arrangements
Mar 05, 2018
Cota to Showcase Real-World Analytics Solution to Drive Oncology Practice Improvement at HIMSS18
Feb 21, 2018
Cota Announces $40 Million Series C Financing to Advance its Cota Nodal Address(TM) Classification System and Real-World Evidence and Analytics Platforms
Feb 06, 2018
Cota Founder and Executive Chairman Honored with Dr. Sol J. Barer Award for Vision, Innovation and Leadership
Jan 17, 2018
Cota Chief Medical Officer to Present at the HealthXL Global Gathering 2018
Jan 03, 2018
Baptist Health South Florida Selects Cota, Inc. to Advance Personalized Cancer Treatment and Research
Dec 20, 2017
Cota Supports Research Efforts Behind Novel Findings Presented at the American Society of Hematology Annual Meeting
Dec 19, 2017
Cota Joined Fellow Innovators at the Health 2.0 Precision Health Summit
Nov 09, 2017
Cota Announces Data and Technology Collaboration with Memorial Sloan Kettering Cancer Center to Advance Personalized Cancer Treatment and Research
Sep 13, 2017
Dr. Andrew Norden, Former IBM Watson Health Deputy Chief Health Officer, Joins Cota as Chief Medical Officer